Biotech company, Biocon will see two crucial inspections later this month and in early April. Company‘s manufacturing sites will come up for inspections by the European medicines agency later this month and next will be an inspection by the US FDA.
first published: Mar 2, 2017 01:45 pm
A collection of the most-viewed Moneycontrol videos.
This Tenant says Andheri West is better than SOBO | The tenant
Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell
Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live
Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live
